NIH-funded research NIH-funded research

Developmental Core for AIDS-related Malignancies in Africa

Official title: Developmental Core

Funded at Lsu Health Sciences Center · NIH-11623229 · Data updated 2026-11-12

This grant supports training and capacity building to improve prevention, diagnosis, care, and treatment of AIDS-related cancers like Kaposi sarcoma in Africa, with opportunities for U.S. and African researchers to collaborate.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLsu Health Sciences Center
NIH-funded
Lab location1 site (New Orleans, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2026
Award (this year)$32,402
NIH project number3U54CA277846-04S2
Project IDNIH-11623229 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people living with HIV in Tanzania and Zambia, particularly those at risk for or affected by AIDS-related malignancies like Kaposi sarcoma, along with early-career researchers from Africa and the United States seeking global health research training.

Less likely to help

Patients not directly affected by HIV-related cancers or not engaged in care improvement activities may not experience direct benefits from this grant.

What this research studies

This program aims to build a sustainable local research enterprise focused on HIV-associated cancers, especially Kaposi sarcoma, in Tanzania and Zambia. It will provide mentoring, training, and career development for investigators in Africa and the United States to strengthen research in immunology, pathology, and implementation science. By linking institutions in Africa with LSU Health Sciences Center in New Orleans, the project seeks to create a regional research network and hands-on experiences for fellows in global health research settings. The initiative emphasizes developing researchers’ leadership and collaboration skills while advancing understanding and management of KS in people living with HIV on ART.

Why it matters

Potential benefit: If successful, patients with HIV-related cancers could receive earlier diagnosis, improved access to care, and more effective, evidence-based treatment options in Africa and through international collaboration.

How similar studies have gone: The grant builds on ongoing cancer research and training programs and aims to expand successful inter-African collaboration and capacity-building activities.

Where this research is happening

  • Lsu Health Sciences Center
    New Orleans, United States
    Active

Researchers

  • Principal investigator: West, John T. — Lsu Health Sciences Center
  • Study coordinator: West, John T.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.